First Time Loading...

Daxor Corp
NASDAQ:DXR

Watchlist Manager
Daxor Corp Logo
Daxor Corp
NASDAQ:DXR
Watchlist
Price: 9.65 USD Market Closed
Updated: Apr 28, 2024
Section:
 

Wall Street
Price Targets

DXR Price Targets Summary
Daxor Corp

Wall Street analysts forecast DXR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DXR is 23.72 USD with a low forecast of 22.22 USD and a high forecast of 25.73 USD.

DXR Lowest Forecast
Wall Street Target
22.22 USD
130% Upside
DXR Average Forecast
Wall Street Target
23.72 USD
146% Upside
DXR Highest Forecast
Wall Street Target
25.73 USD
167% Upside
Lowest
Price Target
22.22 USD
130% Upside
Average
Price Target
23.72 USD
146% Upside
Highest
Price Target
25.73 USD
167% Upside
Daxor Corp Competitors:
Price Targets
LIFE
Lifecare AS
55% Upside
145720
Dentium Co Ltd
33% Upside
RMD
Resmed Inc
5% Downside
B
301367
BMC Medical Co Ltd
83% Upside
LIFE
Lifecare AS
55% Upside
145720
Dentium Co Ltd
33% Upside
RMD
Resmed Inc
5% Downside
B
301367
BMC Medical Co Ltd
83% Upside
2160
Microport Cardioflow Medtech Corp
261% Upside
SWAV
Shockwave Medical Inc
2% Downside
AXGN
AxoGen Inc
110% Upside
CLPT
Clearpoint Neuro Inc
94% Upside

Revenue
Forecast

Revenue Estimate
Daxor Corp

For the last 8 years the compound annual growth rate for Daxor Corp's revenue is -21%. The projected CAGR for the next 4 years is 89%.

-21%
Past Growth
89%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Daxor Corp

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Daxor Corp

The compound annual growth rate of Daxor Corp's net income for the next 4 years is 8%.

N/A
Past Growth
8%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
DXR intrinsic value, competitors valuation, and company profile.
DCF Valuation
DXR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DXR stock valuation using valuation multiples.
Wall Street Estimates
DXR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DXR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DXR's stock price target?
Price Target
23.72 USD

According to Wall Street analysts, the average 1-year price target for DXR is 23.72 USD with a low forecast of 22.22 USD and a high forecast of 25.73 USD.

What is Daxor Corp's Revenue forecast?
Projected CAGR
89%

For the last 8 years the compound annual growth rate for Daxor Corp's revenue is -21%. The projected CAGR for the next 4 years is 89%.

What is Daxor Corp's Net Income forecast?
Projected CAGR
8%

The compound annual growth rate of Daxor Corp's net income for the next 4 years is 8%.

ALPHA SPREAD
Join more than 132,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.